ClinicalTrials.gg
RecruitingNCT07768332Updated Aug 17, 2026

Assessing Outcomes of Three Different Museum-based Social Prescription Programs in Autistic Adults

An interventional study of Independent museum visit and Guided museum visits and group discussions in Autism Spectrum Disorder (ASD, Autism and Autistic Spectrum Disorder (ASD), sponsored by National Taiwan University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-08-17.

Primary conditionAutistic DisorderRegistry: Autism Spectrum DisorderReclassifiedWhy we changed it
Registry
Autism Spectrum Disorder — the first condition term the registry derived for this study.
ClinicalTrials.gg
Autistic Disorder
Why
  1. The study's listed conditions name Autistic Disorder, a narrower term within Autism Spectrum Disorder.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 2 years 2 months after the study started (first participant enrolled May 2024, registered Jul 2026).
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Non-randomized
Ages
18 Years to 50 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-13

Among 12 studies in Autistic Disorder by National Taiwan University Hospital — 6 open to participants now, 6 under way, none of them phase 3. Autistic Disorder · National Taiwan University Hospital.

Started
2024
with 3 others
No phase
6 of 12
3 open now
Registered
12th of 12
by date

Among the 12 studies in Autistic Disorder by National Taiwan University Hospital, this one is one of 4 that started in 2024, is one of 6 with no phase, and was the 12th registered.

Autistic Disorder

1,033 studies on the registry are indexed under Autistic Disorder; 269 are open to participants now.

Browse Autistic Disorder studies →

Open to participants now

6 of the 12 studies in Autistic Disorder by National Taiwan University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 183 Autistic Disorder studies recruiting now, 33 (18%) set no upper age limit and 143 (78%) stop at 75 or younger; 148 take children under 18; 56 take healthy volunteers.

This study: 18 Years to 50 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Autistic Disorder by National Taiwan University Hospital, or all of them as a file.
02

Study summary

This study will examine whether visiting the National Taiwan Museum can support the social and emotional well-being of autistic adults.

The research team plans to recruit 90 autistic adults aged 18 to 50 from the Department of Psychiatry at National Taiwan University Hospital. Participants must have average-range intellectual ability and be able and willing to complete the study activities and assessments. People with serious physical or mental health conditions that would prevent full participation will not be included. Participants must also agree to audio and video recording during the activities.

After an outpatient doctor confirms eligibility, participants will complete questionnaires and choose one of three museum participation options:

  1. Visit the museum once independently.
  2. Join five guided museum visits with group discussions.
  3. Invite a friend to visit the museum together.

Each group will include about 30 participants.

For the guided group, each session will last about 90 minutes and include a professional museum tour, a question-and-answer period, time for independent exploration, and a group discussion. Participants will be encouraged to select exhibits that interest them, record their observations, share their thoughts, listen to others, and respond to different viewpoints.

The five planned museum themes include Taiwan's history and identity, relationships between people and nature, architecture and living spaces, human evolution and the future, and attitudes toward money and financial planning. The discussions will explore everyday topics such as stereotypes, personal values, preferred living environments, hopes for the future, and managing money.

Participants will complete questionnaires before and after the program. These questionnaires will assess areas such as autistic characteristics, social communication, empathy, sensory experiences, comfort with social touch, emotional skills, loneliness, anxiety, depression, and anxiety during social interaction. Participants will also rate how enjoyable, comfortable, safe, interesting, and socially engaging they found the museum activities.

The researchers will compare participants' results before and after the program. They will also compare the three participation options to determine whether independent visits, guided group activities, or visiting with a friend produce different outcomes.

The overall goal is to understand whether museum-based activities can be used as a form of social prescribing to improve social participation, emotional well-being, confidence, and quality of life among autistic adults.

Read the detailed description

This study will evaluate a museum-based social prescribing program for autistic adults with average-range intellectual functioning. Social prescribing is a person-centered approach that connects individuals with nonmedical community resources to support health, well-being, and social participation. Although social prescribing has been applied to people with chronic medical and psychiatric conditions, its effectiveness for autistic adults has not been well established. This study is being conducted through collaboration between the Department of Psychiatry at National Taiwan University Hospital and the National Taiwan Museum.

Approximately 90 autistic adults will be recruited through the outpatient services of National Taiwan University Hospital. After clinical referral and completion of baseline assessments, participants will select one of three museum participation programs, with a target enrollment of approximately 30 participants per group. Because participants choose their preferred program, assignment is nonrandomized.

The three programs are:

  1. **Independent Museum Visit:** Participants will visit the National Taiwan Museum once at a time of their choosing.
  2. **Guided Museum Program:** Participants will attend five structured group sessions, with approximately 10-15 participants per group. Each session will last approximately 90 minutes and will include a museum-guided introduction, a question-and-answer period, independent exploration of selected exhibits, and a facilitated group discussion.
  3. **Museum Visit With a Friend:** Participants will invite a friend or companion to visit the museum with them.

The guided program will use permanent museum exhibitions as prompts for social interaction, reflection, and discussion. Proposed themes include stereotypes and personal identity, relationships between people and nature, ideals and realities of living environments, human evolution and the future, and personal attitudes toward money and financial planning. During the discussion period, participants will share observations or photographs from the exhibits, listen to other participants, provide feedback, and express their own perspectives.

Quantitative assessments will be administered before participation and, for selected measures, after completion of the assigned museum program. Baseline assessments will characterize autism-related traits, social responsiveness, sensory processing, sensory sensitivity, attitudes toward social touch, emotional functioning, loneliness, anxiety, depression, and social interaction anxiety. Post-program assessments will focus on changes in emotional functioning, loneliness, anxiety, depression, and social interaction anxiety, as well as satisfaction with the museum experience.

Participants who complete their selected program may also be invited to take part in a focus group lasting approximately 30-60 minutes. The discussion will explore perceived benefits, difficulties, satisfaction, and recommendations for improving the program. Focus groups will be audio- and video-recorded and transcribed for qualitative analysis.

Quantitative analyses will examine within-participant changes in emotional intelligence, loneliness, anxiety, depression, and social interaction anxiety. Differences among the three participation programs will also be evaluated, including differences in activity satisfaction and changes from baseline. Exploratory analyses will examine whether baseline autism-related, social, and sensory characteristics are associated with program response. Qualitative data will be summarized thematically to identify perceived benefits and areas requiring improvement.

All research records will be identified by study code rather than participant name. Paper records will be stored in locked cabinets, and electronic files, including audio and video recordings, will be stored on password-protected computers. Study data will be retained for 20 years and then destroyed according to institutional procedures.

03

Conditions studied

  • Autism Spectrum Disorder (ASD
  • Autism
  • Autistic Spectrum Disorder (ASD)

Browse trials for

Keywords

  • Autism spectrum disorder
  • ASD
  • autism
  • psychosocial intervention
  • social participation
  • community-based intervention
  • cultural participation
  • autistic adults
  • social prescribing
  • museum-based intervention
04

In context

Autistic Disorder Reclassified

1,033 studies on the registry are indexed under Autistic Disorder; 269 are open to participants now.

This study's planned enrollment of 90 is above the median of 49 across 813 interventional studies indexed under Autistic Disorder.

Browse Autistic Disorder studies →

Lead sponsor

National Taiwan University Hospital is the lead sponsor of 2,617 studies on the registry; 578 are open to participants now.

Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.

Compared within Autistic Disorder, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Autism Spectrum Disorder. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Meet the diagnostic criteria for autism spectrum disorder.
  • Have intellectual functioning within the normal range.
  • Be willing and able to participate in the study procedures.
  • Be willing to attend the relevant museum activities and group discussions, when applicable.
  • Agree to audio and video recording during relevant study activities.

Exclusion criteria

Exclusion Criteria:

  • Are unwilling to complete the required assessments.
  • Have a serious physical or psychiatric condition that limits their physical stamina, emotional capacity, or ability to understand and complete the study procedures.
  • Refuse audio or video recording.
06

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Independent museum visit

    Will visit the museum independently on one occasion

    Behavioral: Independent museum visit

  • Experimental
    Guided museum visits and group discussions

    Will attend five structured museum sessions with a group of approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.

    Behavioral: Guided museum visits and group discussions

  • Experimental
    Museum visit with a friend

    Will invite a friend or companion of their choice to visit the museum with them

    Behavioral: Museum visit with a friend

Interventions

  • BehavioralIndependent museum visit

    Visit the museum independently on one occasion

  • BehavioralGuided museum visits and group discussions

    Participants will attend five structured museum sessions. Each group will include approximately 10 to 15 participants. Every session will consist of a guided museum visit followed by a facilitated group discussion.

  • BehavioralMuseum visit with a friend

    Participants will invite a friend or companion of their choice to visit the museum with them.

07

What researchers measure

Primary outcomes

  1. Activity satisfaction

    Participants will also complete an activity evaluation based on the University College London Museum Wellbeing Questionnaire. The questionnaire contains 12 items rated on a five-point scale from "never" to "always." It assesses whether participants: Felt happy. Became absorbed in the activity. Felt comfortable and relaxed. Felt safe and secure. Enjoyed the company of others. Enjoyed talking with other people. Found the activity new and interesting. Enjoyed taking part. Found the activity arrangement engaging. Considered the activity entertaining. Felt confident while participating. Experienced a sense of physical and emotional well-being after the activity. Higher scores suggest greater satisfaction.

    Time frame: Change from baseline to after the intervention

Secondary outcomes

  1. Loneliness

    Measured using the UCLA Loneliness Scale, a 20-item measure of loneliness and perceived social isolation. Participants indicate how often they experience feelings described in each item. Higher scores indicate more loneliness.

    Time frame: Change from baseline to after the intervention

  2. Emotional intelligence

    The Schutte Emotional Intelligence Scale is a 33-item measure of emotional abilities. It assesses areas such as expressing emotions, understanding one's own emotions, understanding the emotions of others, and using emotions to support problem-solving. Higher scores suggest higher emotional intelligence and functioning.

    Time frame: Change from baseline to after the intervention

  3. Social interaction anxiety

    The Social Interaction Anxiety Scale is a self-report measure of anxiety experienced during interactions with other people. Participants rate how closely each item reflects their usual experiences. Higher scores indicate greater social interaction anxiety.

    Time frame: Change from baseline to after the intervention

  4. Depression

    The Beck Depression Inventory is a 21-item questionnaire used to assess the severity of depressive symptoms. Higher scores indicate more severe depressive symptoms.

    Time frame: Change from baseline to after the intervention

  5. Anxiety

    Measured using the Beck Anxiety Inventory, a 21-item questionnaire that assesses the severity of anxiety symptoms during the previous month. It covers physical symptoms, nervous-system responses, panic-related symptoms, and subjective feelings of anxiety. Higher scores indicate more severe anxiety symptoms.

    Time frame: Change from baseline to after the intervention

Other outcomes

  1. Autistic characteristics

    The Autism Spectrum Quotient is a 50-item questionnaire used to assess autistic characteristics. It may be completed by the participant or an observer. Items are rated using four response options and then converted into binary scores. The total score ranges from 0 to 50, with higher scores indicating more pronounced autistic characteristics.

    Time frame: Change from baseline to after the intervention

  2. Empathy

    The Empathy Quotient is a 40-item questionnaire used to assess empathy-related abilities. It may be completed by the participant or an observer. Items are rated using four response options and converted into binary scores. Lower total scores indicate greater difficulty with empathy.

    Time frame: Change from baseline to after the intervention

  3. Social responsiveness

    The Social Responsiveness Scale is a 65-item measure of autistic characteristics that can be observed in everyday social situations. It assesses social awareness, social information processing, reciprocal social communication, social avoidance, and restricted or repetitive behavior. It may be completed by the participant or a caregiver. Higher scores indicate greater social and behavioral difficulties associated with autism.

    Time frame: Change from baseline to after the intervention

  4. Sensory processing patterns

    The Adolescent/Adult Sensory Profile is a 60-item self-report questionnaire that assesses how individuals respond to sensory experiences in daily life. It covers visual, auditory, tactile, taste and smell, body-position, and activity-related experiences. The measure evaluates four sensory-processing patterns: Low registration. Sensation seeking. Sensory sensitivity. Sensation avoiding.

    Time frame: Change from baseline to after the intervention

  5. Sensory perception

    The Sensory Perception Quotient is a brief 10-item self-report measure of sensitivity across five sensory systems: vision, hearing, touch, taste, and smell. Each sensory area is assessed using two items. Scores from all items are summed to provide an overall sensory-perception score. Higher scores mean greater sensory perception and sensitivity.

    Time frame: Change from baseline to after the intervention

  6. Social touch sensistivity

    The Social Touch Questionnaire is a 20-item self-report measure used to assess comfort or discomfort with social touch. Items are rated on a five-point scale. Half of the items are reverse-scored. Total scores range from 0 to 80, with higher scores reflecting greater discomfort or avoidance related to social touch.

    Time frame: Change from baseline to after the intervention

08

Study locations

1 of 1 sites recruiting
09

References and documents

Publications

  • World Health Organization. (2022). A toolkit on how to implement social prescribing
  • Salovey, P., & Mayer, J. D. (1990). Emotional intelligence. Imagination, Cognition and Personality, 9, 185-211.
  • Saklofske, D. H., Austin, E. J., & Minski, P. S. (2003). Factor structure and validity of a trait emotional intelligence measure. Personality and Individual Differences, 34, 1091-1100.
  • Petrides, K. V., & Furnham, A. (2000). On the dimensional structure of emotional intelligence. Personality and Individual Differences, 29, 313-320.
  • Zheng YP, Wei LA, Goa LG, Zhang GC, Wong CG. Applicability of the Chinese Beck Depression Inventory. Compr Psychiatry. 1988 Sep-Oct;29(5):484-9. doi: 10.1016/0010-440x(88)90063-6. PubMed 3180758 ↗
  • Yadav UN, Paudel G, Ghimire S, Khatiwada B, Gurung A, Parsekar SS, Mistry SK. A rapid review of opportunities and challenges in the implementation of social prescription interventions for addressing the unmet needs of individuals living with long-term chronic conditions. BMC Public Health. 2024 Jan 27;24(1):306. doi: 10.1186/s12889-024-17736-2. PubMed 38279079 ↗
  • Chrostek E, Teixeira L. Within host selection for faster replicating bacterial symbionts. PLoS One. 2018 Jan 18;13(1):e0191530. doi: 10.1371/journal.pone.0191530. eCollection 2018. PubMed 29346449 ↗
  • Wilhelm FH, Kochar AS, Roth WT, Gross JJ. Social anxiety and response to touch: incongruence between self-evaluative and physiological reactions. Biol Psychol. 2001 Dec;58(3):181-202. doi: 10.1016/s0301-0511(01)00113-2. PubMed 11698114 ↗
  • Wildman JM, Moffatt S, Steer M, Laing K, Penn L, O'Brien N. Service-users' perspectives of link worker social prescribing: a qualitative follow-up study. BMC Public Health. 2019 Jan 22;19(1):98. doi: 10.1186/s12889-018-6349-x. PubMed 30670001 ↗
  • Simpson S, Furlong M, Giebel C. Exploring the enablers and barriers to social prescribing for people living with long-term neurological conditions: a focus group investigation. BMC Health Serv Res. 2021 Nov 13;21(1):1230. doi: 10.1186/s12913-021-07213-6. PubMed 34774034 ↗
  • Mulligan K, Bhatti S, Rayner J, Hsiung S. Social Prescribing: Creating Pathways Towards Better Health and Wellness. J Am Geriatr Soc. 2020 Feb;68(2):426-428. doi: 10.1111/jgs.16249. Epub 2019 Dec 16. No abstract available. PubMed 31840796 ↗
  • Moffatt S, Steer M, Lawson S, Penn L, O'Brien N. Link Worker social prescribing to improve health and well-being for people with long-term conditions: qualitative study of service user perceptions. BMJ Open. 2017 Jul 16;7(7):e015203. doi: 10.1136/bmjopen-2016-015203. PubMed 28713072 ↗
  • Mistry SK, Harris E, Li X, Harris MF. Feasibility and acceptability of involving bilingual community navigators to improve access to health and social care services in general practice setting of Australia. BMC Health Serv Res. 2023 May 11;23(1):476. doi: 10.1186/s12913-023-09514-4. PubMed 37170092 ↗
  • Luo N, Fones CS, Thumboo J, Li SC. Factors influencing health-related quality of life of Asians with anxiety disorders in Singapore. Qual Life Res. 2004 Mar;13(2):557-65. doi: 10.1023/B:QURE.0000018484.89711.e2. PubMed 15085928 ↗
  • Kim YS, Leventhal BL, Koh YJ, Fombonne E, Laska E, Lim EC, Cheon KA, Kim SJ, Kim YK, Lee H, Song DH, Grinker RR. Prevalence of autism spectrum disorders in a total population sample. Am J Psychiatry. 2011 Sep;168(9):904-12. doi: 10.1176/appi.ajp.2011.10101532. Epub 2011 May 9. PubMed 21558103 ↗
  • Kiely B, Connolly D, Clyne B, Boland F, O'Donnell P, Shea EO, Smith SM. Primary care-based link workers providing social prescribing to improve health and social care outcomes for people with multimorbidity in socially deprived areas (the LinkMM trial): Pilot study for a pragmatic randomised controlled trial. J Multimorb Comorb. 2021 May 20;11:26335565211017781. doi: 10.1177/26335565211017781. eCollection 2021 Jan-Dec. PubMed 34094992 ↗
  • Hanlon P, Gray CM, Chng NR, Mercer SW. Does Self-Determination Theory help explain the impact of social prescribing? A qualitative analysis of patients' experiences of the Glasgow 'Deep-End' Community Links Worker Intervention. Chronic Illn. 2021 Sep;17(3):173-188. doi: 10.1177/1742395319845427. Epub 2019 May 3. PubMed 31053038 ↗
  • Greenberg DM, Warrier V, Allison C, Baron-Cohen S. Testing the Empathizing-Systemizing theory of sex differences and the Extreme Male Brain theory of autism in half a million people. Proc Natl Acad Sci U S A. 2018 Nov 27;115(48):12152-12157. doi: 10.1073/pnas.1811032115. Epub 2018 Nov 12. PubMed 30420503 ↗
  • Gibson K, Pollard TM, Moffatt S. Social prescribing and classed inequality: A journey of upward health mobility? Soc Sci Med. 2021 Jul;280:114037. doi: 10.1016/j.socscimed.2021.114037. Epub 2021 May 16. PubMed 34033978 ↗
  • Drinkwater C, Wildman J, Moffatt S. Social prescribing. BMJ. 2019 Mar 28;364:l1285. doi: 10.1136/bmj.l1285. No abstract available. PubMed 30923039 ↗
  • Chien IC, Lin CH, Chou YJ, Chou P. Prevalence and incidence of autism spectrum disorders among national health insurance enrollees in Taiwan from 1996 to 2005. J Child Neurol. 2011 Jul;26(7):830-4. doi: 10.1177/0883073810393964. Epub 2011 Apr 1. PubMed 21460178 ↗
  • Chen YL, Chen WJ, Lin KC, Shen LJ, Gau SS. Prevalence of DSM-5 mental disorders in a nationally representative sample of children in Taiwan: methodology and main findings. Epidemiol Psychiatr Sci. 2019 Jan 30;29:e15. doi: 10.1017/S2045796018000793. PubMed 30696515 ↗
  • Carnes D, Sohanpal R, Frostick C, Hull S, Mathur R, Netuveli G, Tong J, Hutt P, Bertotti M. The impact of a social prescribing service on patients in primary care: a mixed methods evaluation. BMC Health Serv Res. 2017 Dec 19;17(1):835. doi: 10.1186/s12913-017-2778-y. PubMed 29258514 ↗
  • Brandling, J., & House, W. (2007). Investigation into the feasibility of a social prescribing service in primary care: a pilot project. University of Bath and North East Somerset NHS Primary Care Trust
  • BECK AT, WARD CH, MENDELSON M, MOCK J, ERBAUGH J. An inventory for measuring depression. Arch Gen Psychiatry. 1961 Jun;4:561-71. doi: 10.1001/archpsyc.1961.01710120031004. No abstract available. PubMed 13688369 ↗
  • https://www.tandfonline.com/doi/abs/10.1207/s15327752jpa6703_13
  • Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988 Dec;56(6):893-7. doi: 10.1037//0022-006x.56.6.893. No abstract available. PubMed 3204199 ↗
  • Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord. 2001 Feb;31(1):5-17. doi: 10.1023/a:1005653411471. PubMed 11439754 ↗
  • American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC
  • American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders (4th ed.). American Psychiatric Association.

Individual participant data

Plan to share: Undecided

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Dec 2027, 43 months after the start.

Of 355 non-industry interventional studies with no phase under Autistic Disorder, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 52. This study's planned 43 months is above that.

Counting every sponsor, half of 367 studies reached it within 26 months; a quarter within 13 and three quarters within 52.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 29, 2026
First posted
Aug 17, 2026
StartActual
May 1, 2024
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Aug 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT07768332
Collaborators
National Taiwan Museum
Responsible party
Sponsor
First posted
Aug 17, 2026
Start date
May 1, 2024
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Aug 17, 2026

Study contacts

Yi-Ling Chien, MD, PhD
Contact
ntuh.peers@gmail.com
+866+223123456 ext. 266013

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion